NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
PharmGen Science Inc (KO: 004720)
004720 Technical Analysis
5
As on 11th Jul 2023 004720 SHARE Price closed @ 5620.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7946.74 & Strong Sell for SHORT-TERM with Stoploss of 9508.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
004720SHARE Price
Open | 5500.00 | Change | Price | % |
High | 5620.00 | 1 Day | 100.00 | 1.81 |
Low | 5490.00 | 1 Week | -230.00 | -3.93 |
Close | 5620.00 | 1 Month | -580.00 | -9.35 |
Volume | 65461 | 1 Year | -4430.00 | -44.08 |
52 Week High 10650.00 | 52 Week Low 5620.00 |
KO Korea Most Active Stocks
001470 | 4730.00 | -4.25% |
001470 | 4730.00 | -4.25% |
010600 | 2780.00 | 29.91% |
010600 | 2780.00 | 29.91% |
096300 | 156.00 | -6.02% |
096300 | 156.00 | -6.02% |
011930 | 2655.00 | 3.51% |
011930 | 2655.00 | 3.51% |
272210 | 17220.00 | 12.99% |
272210 | 17220.00 | 12.99% |
KO Korea Top Gainers Stocks
KO Korea Top Losers Stocks
004720 Daily Charts |
004720 Intraday Charts |
Whats New @ Bazaartrend |
004720 Free Analysis |
|
004720 Important Levels Intraday
RESISTANCE | 5870.51 |
RESISTANCE | 5790.17 |
RESISTANCE | 5740.51 |
RESISTANCE | 5690.85 |
SUPPORT | 5549.15 |
SUPPORT | 5499.49 |
SUPPORT | 5449.83 |
SUPPORT | 5369.49 |
004720 Forecast April 2024
4th UP Forecast | 11092.7 |
3rd UP Forecast | 9337.56 |
2nd UP Forecast | 8252.68 |
1st UP Forecast | 7167.8 |
1st DOWN Forecast | 4072.2 |
2nd DOWN Forecast | 2987.32 |
3rd DOWN Forecast | 1902.44 |
4th DOWN Forecast | 147.32 |
004720 Weekly Forecast
4th UP Forecast | 7450.65 |
3rd UP Forecast | 6863.55 |
2nd UP Forecast | 6500.65 |
1st UP Forecast | 6137.75 |
1st DOWN Forecast | 5102.25 |
2nd DOWN Forecast | 4739.35 |
3rd DOWN Forecast | 4376.45 |
4th DOWN Forecast | 3789.35 |
004720 Forecast2024
4th UP Forecast | 17394 |
3rd UP Forecast | 13618 |
2nd UP Forecast | 11284 |
1st UP Forecast | 8949.95 |
1st DOWN Forecast | 2290.05 |
2nd DOWN Forecast | -43.97 |
3rd DOWN Forecast | -2377.99 |
4th DOWN Forecast | -6153.97 |
PharmGen Science Inc ( KO Korea Symbol : 004720 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
004720 Other Details
Segment | EQ | |
Market Capital | 170183606272.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-General | |
Offical website | > echo $website ; ?> |
004720 Address
004720 Latest News
004720 Business Profile
PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It offers prescription drugs, OTC drugs, health food, and cosmetics. It offers its products in the form of tablet, hard capsule, granule and ointment, syrups, and suspension forms. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1961 and is headquartered in Hwaseong, South Korea. Address: 50, Jeyakgongdan 2-gil, Hwaseong-si, South Korea
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service